National Research (NASDAQ:NRC) Shares Pass Above 200-Day Moving Average – What’s Next?

National Research Corporation (NASDAQ:NRC)’s stock price crossed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $17.63 and traded as high as $18.59. National Research shares last traded at $18.47, with a volume of 84,418 shares trading hands.

Wall Street Analyst Weigh In

Separately, Weiss Ratings raised National Research from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, May 29th. One analyst has rated the stock with a Hold rating, According to MarketBeat.com, the company has a consensus rating of “Hold”.

National Research Stock Up 0.9%

The company has a market cap of $420.19 million, a P/E ratio of 47.36 and a beta of 0.37. The company has a 50 day moving average of $18.38 and a 200-day moving average of $17.63. The company has a debt-to-equity ratio of 5.48, a current ratio of 0.52 and a quick ratio of 0.52.

National Research (NASDAQ:NRC) last issued its quarterly earnings results on Tuesday, April 28th. The company reported $0.21 earnings per share (EPS) for the quarter. National Research had a return on equity of 122.73% and a net margin of 6.52%.The firm had revenue of $34.80 million during the quarter.

National Research Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 10th. Shareholders of record on Friday, June 26th will be paid a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, June 26th. This represents a $0.64 annualized dividend and a yield of 3.5%. National Research’s payout ratio is 164.10%.

Institutional Investors Weigh In On National Research

Several hedge funds have recently added to or reduced their stakes in the company. M&T Bank Corp lifted its stake in National Research by 6.4% during the second quarter. M&T Bank Corp now owns 13,608 shares of the company’s stock worth $229,000 after purchasing an additional 823 shares during the last quarter. Sei Investments Co. lifted its stake in National Research by 1.2% during the third quarter. Sei Investments Co. now owns 76,270 shares of the company’s stock worth $975,000 after purchasing an additional 900 shares during the last quarter. Russell Investments Group Ltd. lifted its stake in National Research by 85.6% during the third quarter. Russell Investments Group Ltd. now owns 1,997 shares of the company’s stock worth $26,000 after purchasing an additional 921 shares during the last quarter. Invesco Ltd. lifted its stake in National Research by 6.3% during the second quarter. Invesco Ltd. now owns 17,368 shares of the company’s stock worth $292,000 after purchasing an additional 1,022 shares during the last quarter. Finally, Alliancebernstein L.P. lifted its stake in National Research by 6.3% during the third quarter. Alliancebernstein L.P. now owns 18,499 shares of the company’s stock worth $236,000 after purchasing an additional 1,100 shares during the last quarter. Institutional investors own 47.26% of the company’s stock.

About National Research

National Research Corp (NASDAQ: NRC), also known as NRC Health, is a healthcare analytics and performance improvement company specializing in patient and employee experience measurement. The company’s cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. NRC Health integrates clinical, operational and financial data to deliver actionable insights that support quality improvement initiatives and value-based care programs.

Since its founding in the early 1990s and headquartered in Lincoln, Nebraska, National Research has expanded beyond its regional roots to serve more than 1,600 hospitals and 12,000 care sites across the United States and Canada.